GSK:LON
GSK plc
GBX १,७७०.८३
arrow_upward
+१.१९%(+२०.८३) 1D
अक्टोबर १२, १८:१७:१६ GMT+१ · GBX
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GSK...
Open
GBX १,७५५.००
High
GBX १,७७१.००
Low
GBX १,७५१.००
Mkt. cap
९४.४७ अरब
Avg. vol.
५९.०३ लाख
Volume
३१.५२ लाख
Dividend
३.८४%
Quarterly dividend
GBX १७.००
Ex-dividend date
२०२६ अगस्ट १३
P/E ratio
१५.०१
52-wk high
GBX २,२८२.००
52-wk low
GBX १,५९२.००
EPS
GBX १.१८
Shares outstanding
४.३२ अरब
No. of employees
६७ हजार
Open
GBX १,७५५.००
High
GBX १,७७१.००
Low
GBX १,७५१.००
Mkt. cap
९४.४७ अरब
Avg. vol.
५९.०३ लाख
Volume
३१.५२ लाख
Dividend
३.८४%
Quarterly dividend
GBX १७.००
Ex-dividend date
२०२६ अगस्ट १३
P/E ratio
१५.०१
52-wk high
GBX २,२८२.००
52-wk low
GBX १,५९२.००
EPS
GBX १.१८
Shares outstanding
४.३२ अरब
No. of employees
६७ हजार
News stories
From web sources and news partners
Patch
·
५ घण्टा पहिले
Pharma Giant GSK To Expand In Upper Merion, Investing $800 Million
TipRanks
·
७ घण्टा पहिले
GSK Executives Reinvest Dividends in Routine Share Acquisitions
Endpoints News
·
७ घण्टा पहिले
GSK to invest $800M for new R&D, manufacturing hub in Pennsylvania
Kalkine Media
·
११ घण्टा पहिले
Is GSK (LSE:GSK) Shares' Dip After The Nuvalent Deal A Pipeline Story In Focus?
Profile
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
About GSK plc
CEOEmma Walmsley | Emma Walmsley
Employees६६.८ हजार
Founded२००० डिसेम्बर २७
Headquarters-
Sector-
Websitegsk.com